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Background: MicroRNAs (miRNAs) are short, non-coding RNAs that negatively regulate target genes. A single
nucleotide polymorphism (SNP) in a miRNA sequence may alter miRNA expression and/or maturation, which was
proposed to associate with the development and progression of cancer. The rs895819 polymorphism, located in the
terminal loop of pre-miR-27a, has been reported to have relevance to several cancers. In this study, we investigated the
possibility of association between polymorphism in rs895819 and susceptibility to colorectal cancer (CRC).
Methods: We identified a single SNP, rs895819 in pre-miR-27a, for further investigation, were determined in 205 CRC
patients and 455 healthy controls.
Results: When taking the AA genotype as a reference, we found that AG genotype was not statistically significantly
associated with the risk of CRC (AG vs. AA, OR 1.245, 95% CI: 0.806 – 1.923). However, the GG genotype was significantly
associated with risk of CRC (GG vs. AA, OR 1.599, 95% CI: 1.052 – 2.430). In the AG + GG vs GG group, no significant
difference was detected (OR 1.424, 95% CI, 0.974 – 1.801). GG genotype and G allele was associated with an increased
risk of metastasis in this study (P < 0.001 and P = 0.003, respectively).
Conclusions: This study found significant association between rs895819 polymorphism in pre-miR-27a and CRC risk.
Population-based studies with large number of subjects and long-term follow-up are needed to verify the association of
miR-27a polymorphism with CRC susceptibility and severity.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
2061490734125077
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Colorectal cancer (CRC) is reported to be the third most
common cancer worldwide with an estimated one
million new cases and it is one of the most frequent
cancers and a common cause of cancer-related deaths
[1-3]. Improvements of diagnosis and treatment had
resulted in improved long-term survival rates for patients
with early CRC, whereas the outlook for individuals with
advanced disease remains poor. Advanced CRC frequently
recurs as nodal and hematogenous metastasis and
peritoneal dissemination [4]. Although several types
of non-surgical treatments have been assessed, surgery
is the primary treatment for CRC, and if the tumor is* Correspondence: prhusanyuan@163.com
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unless otherwise stated.caught at a sufficiently early stage, surgery can be
curable. The nature of the disease is, however, such
that it often presents at an advanced stage, and so
surgery alone is insufficient [5].
CRC development involves a multi-step process
including both genetic and epigenetic changes, which
leads to activation of oncogenes and inactivation of tumor
suppressor genes in cancer cells [6]. MicroRNAs (miRNAs)
are short, non-coding RNAs of approximately 23
nucleotides that negatively regulate target genes. MiRNAs
have been implicated in several biochemical pathways in
the eukaryotic cells of various organisms [7]. As a
posttranscriptional regulator, miRNAs bind to complemen-
tary sequences on target messenger RNAs (mRNAs),
resulting in mRNA degradation or translational repression.
Sequences encoding the miRNA precursor are usually
transcribed by RNA polymerase II to generate primarytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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miRNA and cancer has been recently reported. MiRNAs
have been proposed to contribute to tumorigenesis as
either tumor suppressors or oncogenes [8]. A single
nucleotide polymorphism (SNP) is a single nucleotide
variation of a DNA sequence, A (adenine), T (thymine), C
(cytosine), or G (guanine), on genomic DNA. A SNP in a
miRNA sequence may alter miRNA expression and/or
maturation and be associated with the development and
progression of cancer [9].
The relationship between miR-27a and several different
cancers have been discussed. Tang et al. reported that the
expression of miR-27a was significantly correlated with
clinic pathological parameters, including tumor size, lymph
node metastasis and distant metastasis, but not with recep-
tor status [10]. Patients with high miR-27a level tended to
have significantly shorter disease-free survival durations
and overall survival times [10]. It was also reported that
the expression of miR-27a was higher in human ovarian
cancer relative to benign ovarian tissues. Transfection of
SKOV3 cells with the miR-27a inhibitor could suppress the
growth and migration of tumor cells [11].
We utilized public databases to identify deregulated
miRNAs in CRC and SNPs in these miRNAs sequences,
including primary, precursor and mature miRNAs. Our
searches identified a single SNP, rs895819 in pre-miR-27a,
for further investigation. The rs895819 polymorphism is
located in the terminal loop of pre-miR-27a and involves
an AG nucleotide transition. The association between
rs895819 polymorphism and risk of several cancers
were reported [12-14]. In this study, we investigated
the possibility of association between polymorphism
in rs895819 and susceptibility to CRC.
Methods
Ethics statement
This study was approved by the institutional review
board of Qilu Hospital of Shandong University. All
the participants were voluntary and provided written
informed consent prior to taking part in this research.
Study subjects
All subjects were recruited from Qilu Hospital of
Shandong University between January 2010 and December
2013. They were all newly diagnosed, histopathologically
confirmed and without a prior history of cancer or
previous chemo- or radiotherapy. In all, 205 patients with
CRC were recruited, all of whom were unrelated ethnic
Han Chinese population. A structured questionnaire on
demographics and environmental exposure, including age,
sex, smoking consumption and alcohol drinking, was
conducted by trained interviewers through face-to-face
interviews with the patients. In addition, 5 ml venous
blood was collected from each patient for genomic DNAextraction. The clinical characters of all cases were
recorded by reviewing the databases or counseling the
doctor.
DNA extraction
For both the cases and control cohorts, 1.5 ml of
whole blood was extracted from each participant and
stored at −80°C before being used. DNA from each
sample of whole blood was extracted with the QIAamp
DNA mini Kit (Qiagen, Hilden, Germany), as directed by
the manufacturer's instructions. The concentration of
DNA and the purity of each sample were measured by an
ultraviolet spectrophotometer (GE Healthcare, USA).
DNA samples were routinely stored at − 20°C.
SNP genotyping analysis
Genotyping was performed by TaqMan allelic discrimin-
ation assays using an ABI 7900 system (Applied Biosystems,
Foster City, CA, USA). The prime and probes are as
follows: forward, GGCGGAACTTAGCCACTGT, reverse,
CAGGGCTTAGCTGCTTGTG. The TaqMan assays were
performed in a final reaction volume of 5 ml containing
0.25 ml primer, 0.125 ml probe, 2 ml PCR mixture reagent
and 25 ng DNA. The PCR reaction consisted of an initial
step at 95 uC for 10 min followed by 55 cycles of denaturing
at 95 uC for 15 s and annealing at 60 uC for 60 s. SDS allelic
discrimination software (ABI) was used to analyze the
PCR genotyping results. Two blank (water) controls were
included in each 384-well assay. At least 10% of samples
were randomly selected for repeat analysis, yielding 100%
concordance. A further 60 samples were selected randomly
for direct sequencing to confirm the TaqMan results. Again,
the results showed 100% concordance.
Statistical analysis
Statistical analysis was performed using the SPSS 20.0
software package (SPSS Company, Chicago, IL).
Hardy–Weinberg equilibrium analysis was performed
using a goodness-of-fit χ2 -test with one degree of
freedom. P < 0.05 was considered representative of a
departure from HWE. Comparison of allele type and
genotype distributions in the patients and healthy controls
were performed by means of two-sided contingency
tables using the χ2 -test. The odds ratio (OR) and
95% confidence interval (CI) for genotypic-specific
risk were calculated using an unconditional logistic
regression model. P < 0.05 was considered significant
for all statistical analyses.
Result
General characteristics of the subjects
A total of 205 CRC patients and 455 healthy controls
were enrolled in our study. All of the subjects were
ethnic Han Chinese. Demographic and other selected
Table 1 General characteristics of colorectal cancer (CRC) patients and controls
Variable s Cases Percentage (%) Control Pecentage (%) P value OR (95% CI)
Age (years, mean ± SD) 54.9 ± 11.2 55.4 ± 10.1 0.15
Sex
Male 103 50.24 225 49.45 1 (Ref)
Female 102 49.76 230 50.55 0.859 1.032 (0.742 - 1.435)
Smoking status
No 61 29.76 201 44.18 1 (Ref)
Yes 144 70.24 254 55.82 < 0.001 1.868 (1.314 - 2.656)
Smoking amount (pack-years)
0 61 29.76 201 44.18 1 1 (Ref)
< 1500 51 24.87 123 27.03 0.453 1.21 (0.88 – 2.11)
> 1500 93 45.36 131 28.79 < 0.001 2.34 (1.58 -3.46)
Smoking duration (years)
0 61 29.76 201 44.18 (Ref) 1
< 5 12 5.85 37 8.13 0.325 1.069 (0.525 – 2.177)
5 - 10 39 19.02 81 17.80 0.067 1.587 (0.984 – 2.558)
> 10 93 45.36 150 32.97 0.002 2.43 (1.389 – 3.005)
Alcohol
No 89 43.41 236 51.87 1 (Ref)
Yes 116 56.59 219 48.13 0.044 1.405 (1.008 - 1.957)
Alcohol amount (cups/day)
0 89 43.41 236 51.87 1 (Ref)
1 – 3 39 19.02 102 22.42 0.284 1.014 (0.651 – 1.578)–
> 3 77 38.54 117 26.71 0.012 1.790 (1.230 – 2.606)
Alcohol use duration
0 89 43.41 236 51.87 1 (Ref)
< 5 32 15.61 78 17.53 0.329 1.088 (0.674 – 1.755)
5 - 10 29 14.15 65 14.61 0.436 1.183 (0.717 – 1.953)
> 10 55 26.83 76 17.08 < 0.001 1.919 (1.256 – 2.933)
Fruit intake (times/week)
≤ 1 68 33.17 120 26.97 1 (Ref)
2-4 53 25.85 165 37.07 0.042 0.588 (0.380 – 0.899)
≥ 5 84 40.98 170 38.20 0.245 0.872 (0.587 – 1.296)
Vegetable intake (times/week)
≤ 1 85 41.46 116 26.07 1 (Ref)
2-4 75 36.59 131 29.43 0.546 0.781 (0.524 – 1.164)
≥ 5 45 21.95 198 44.49 < 0.001 0.310 (0.202 – 0.476)
Education status
High school or less 109 228 1 (Ref)
College or University 81 202 0.839 (0.594 – 1.183)
Master or more 15 15 2.092 (0.987 – 4.434)
Income (RMB/year)
≤ 100,000 98 47.80 109 24.49 1 (Ref)
100,000 – 300,000 88 42.93 252 56.12 0.001 0.388 (0.270 – 0.560)
≥300,000 19 9.27 84 18.88 < 0.001 0.252 (0.143 – 0.444)
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Table 1. Cases and controls did not show statistically
significant differences with regard to sex and age. However,
the higher smoking and alcohol drinking were risks of
CRC (P = 0.001, OR = 1.868; P = 0.044, OR = 1.405,
respectively). When the duration or amount was
considered, higher amount (OR, 2.34, 95% CI, 1.58 -3.46)
and duration (OR, 2.43; 95% CI, 1.389 – 3.005) of tobacco
smoking were associated with the risk of CRC. Besides, the
higher amount of alcohol consumption was associated with
higher risk of CRC (OR, 1.790; 95% CI, 1.230 – 2.606). In
the advanced analyses, the results showed that high intake
of vegetable (OR, 0.310; 95% CI, 0.202 – 0.476) and fruit in-
take (OR, 0.588; 95% CI, 0.380 – 0.899) was associated with
reduced risk of CRC incidence. The education statuses
were not associated with the risk of CRC, while lower
income might lead to high incidence of CRC (OR,
0.252; 95% CI, 0.143 – 0.444).
With regard to clinic pathologic characteristics of
CRC patients, most patients had a smaller tumor size
(less than 5 cm, 65.85%). Well-moderately status was in
126 (61.46%) patients, while poorly-undifferentiated status
was in 79 (38.54%) patients. A total of 86 patients
(41.95%) had metastasis among all the patients. According
to the TNM classification criteria, 138 and 67 patients
were in stage I-II and III-IV, respectively (Table 2).Table 2 Clinical characteristics of colorectal cancer (CRC)
patients and controls
Variables Cases Percentage (%)
Tumor size
<5 cm 135 65.85
















Local resection 23 11.21
Chemotherapy 56 27.31The effect of the rs895819 polymorphism on the risk
of CRC
The genotype and allele frequencies of the rs895819 were
presented in Table 3. The genotype frequencies in both
cases and controls were in agreement with the HWE
model. As shown in Table 3, the genotype frequencies of
the rs895819 were 11.71, 39.02 and 49.27% for the AA,
AG, and GG genotypes respectively, among the CRC
group; and 30.33, 34.51 and 35.16% among the controls,
respectively. When taking the AA genotype as a reference,
we found that AG genotype was not statistically
significantly associated with the risk of CRC (AG vs. AA,
OR 1.245, 95% CI: 0.806 – 1.923). However, compared
with AA genotype, the GG genotype was significantly
associated with risk of CRC (GG vs. AA, OR 1.599,
95% CI: 1.052 – 2.430). In the AG+GG vs GG group,
no significant difference was detected (OR 1.424, 95%
CI, 0.974 – 1.801).
Besides, the allele distribution was significant difference
between cases and controls (OR 1.362, 95% CI 1.075 -
1.725). Taken together, these data suggest that the miR-27a
binding site polymorphism rs895819 may be associated
with the risk of CRC.
The rs895819 polymorphism and clinicopathological
characteristics
In the stratified studies, we attended to detect the association
between rs895819 polymorphism and clinicopathological
characteristics of patients with CRC. We observed no
association between rs895819 polymorphism and the
progression of CRC including tumor size and tumor
stage. However, GG genotype and G allele was associated
with an increased risk of metastasis in this study (P < 0.001
and P = 0.003, respectively) (Table 4).
Discussion
According to the polygenic model of carcinogenesis,
unfavorable combinations of polymorphic genetic variants
in low-penetrance susceptibility genes contribute to
increasing CRC risk. Studies have shown that profiles of
miRNA expression differ between normal and tumor
tissues, which vary among tumor types and the
down-regulation of miRNA subsets implies a tumor-
suppressor function, which is often observed in tumor
development. Recently, a class of novel functional poly-
morphisms in miRNAs or their binding sites has attracted
great interest. One important SNP in pre-mir-27a of an A
to G change was identified as rs895819, and its role in
cancer susceptibility has been discussed recently [14,15].
Though many studies have been performed, whether
rs895819 contributes to cancer susceptibility is still
unclear, and the association between rs895819 and
CRC risk remains unknown. Therefore, our present
study investigated the association of rs895819 with
Table 3 Genotypes of rs895819 polymorphism and CRC risk
Genotype Cases Percentage (%) Control Pecentage (%) P value OR (95% CI)
AA 48 11.71 138 30.33 1 (Ref)
AG 68 39.02 157 34.51 0.087 1.245 (0.806 – 1.923)
GG 89 49.27 160 35.16 0.015 1.599 (1.052 – 2.430)
AG + GG 157 88.29 317 69.67 0.064 1.424 (0.974 – 1.801)
Allele frequency
A allele 164 32.22 433 49.58 1 (Ref)
G allele 246 67.78 477 50.42 0.027 1.362 (1.075 – 1.725)
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study with 205 cases and 455 controls, our study
demonstrated that subjects with GG genotype and the
G allele exhibited a significantly increased risk of
CRC in the cohort. Advanced study on the association
between rs895819 and the clinical pathological characters
showed that GG genotype and the G allele were risk
factors of increased risk of CRC.
A previous study by Fu et al. identified 32 differentially
expressed miRNAs and 2916 mRNAs from CRC samples
and their corresponding normal epithelial tissues by
miRNA and mRNA microarray, respectively. Additionally,
6 up-regulated miRNAs (mir-21, mir-223, mir-224,
mir-29a, mir-29b, and mir-27a) and 4 down-regulated
predicted target mRNAs (SFRP1, SFRP2, RNF138, and
KLF4) were selected to validate the expression level
and their anti-correlationship in an extended cohort
of CRC patients by qRT-PCR [16]. In animal model, it was
also reported that a recurrent amplicon on mouse
chromosome 8 that encodesmiR-23a and -27a levels are
up-regulated in mouse intestinal adenocarcinomas, pri-
mary tumors from patients with stage I/II colorectal
cancers, as well as in human colorectal cancer cell
lines and cancer stem cells [11]. It could be presumed that
miR-27a might play a key role in the development and
progression of CRC. Some more studies were alsoTable 4 Clinicopathological characteristics and miR-27a
genotype and allelic frequencies of CRC patients
Genotype P value Allele
AA AG GG AG vs AA GG vs AA A G P value
Tumor size
<5 cm 33 40 62 103 162
≥5 cm 16 20 34 0.784 0.812 52 88 0.734
TNM stage
I-II 32 43 60 105 163
III- IV 15 21 34 0.729 0.617 51 89 0.587
Metastasis
Yes 19 20 47 58 114
No 28 31 69 0.903 < 0.001 87 169 0.003conducted to identify the potential role of miR-27a in
CRC. Kim et al. showed that human miR-27a* is a
negative regulator of NK-cell cytotoxicity by silencing
Prf1 and GzmB expression. Human miR-27a* specifically
bound to the 3' untranslated regions of Prf1 and GzmB,
down-regulating expression in both resting and activated
NK cells, and it functioned as a fine-tuner for homeostasis
of the net amount of the effectors proteins. Consistent
with miR-27a* having an inhibitory role, knockdown of
miR-27a* in NK cells dramatically increased cytotoxicity
in vitro and decreased tumor growth in a human tumor
xenograft model. Thus, NK-cell cytotoxicity is regulated,
in part, by microRNA, and modulating endogenous
miR-27a* levels in NK cells represents a potential immuno-
therapeutic strategy [17]. Resveratrol and quercetin (RQ) in
combination (1:1 ratio) could produce a significant antican-
cer effect through decreasing the miR-27a level in colon
cancer cell lines [18]. This was confirmed by transfection of
cells with the specific mimic for miR-27a, which partially
reversed the effects of RQ.
Single nucleotide polymorphism of miRNA would influ-
ence the expression of miRNA and thus would influence
the cancer incidence or progression. Zhou et al. [19]
reported that 19 SNPs of the miRNA-related genes in
a case–control study of 311 gastric cancers and 425
cancer-free controls in a Chinese Han population. The
results showed that the SNP rs895819 in the miR-27a
gene with the minor allele C presented significantly
reduced risk to gastric cancer (p = 0.037, OR = 0.771,
95% CI = 0.604 - 0.985). Wang et al. [20] conducted a
meta-analysis of miR-27a SNP and risk of breast cancer.
They found that hsa-mir-27a rs895819 polymorphism also
did not reveal any relationship with breast cancer suscepti-
bility, while significantly decreased risk was found among
Europeans in AG versus AA and AG/GG versus AA
models tested (AG versus AA: OR= 0.83; 95% CI, 0.72-0.97;
GG versus AA: OR= 0.86; 95% CI, 0.71-1.05; AG/GG
versus AA: OR= 0.84; 95% CI, 0.75-0.94).
The association between miR-27a SNP and CRC risk
was also studied in several studies. Hezova R et al. [21]
conducted a case–control study to investigate whether
selected single nucleotide polymorphisms (SNPs) in
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with sporadic colorectal cancer (CRC). The results of this
case–control study of 197 cases of sporadic CRC and 212
cancer-free controls originating from the Central-European
Caucasian population showed that there was a lack of asso-
ciation between rs11614913, rs895819 and rs2910164 and
colorectal cancer risk in the Central-European Caucasian
population. This result was contradictory with our study.
The potential explanations were the difference between the
locality and races included in the two studies. The genetic
background and environmental factors might influence the
effect of rs895819 on the risk of CRC.
Conclusion
Our results showed an association between miR-27a
polymorphism and CRC in Chinese Han patients. Besides,
miR-27a polymorphism showed a significant association
with the risk of metastasis. However, no functional valid-
ation of these observational findings was conducted and a
series of following studies would be conducted. Considering
that this is from a case-control study, however, population-
based studies with large number of subjects and long-term
follow-up are needed to verify the association of miR-27a
polymorphism with CRC susceptibility and severity.
Competing interests
The authors declare that they have no competing interests.
Authors’ contribution
WZQ, WYL and HSY provided the conduction of the whole project, WZQ,
SXL, WYL, LXF, XYJ and HSY performed the research, WZQ, SXL, WYL, LXF,
XYJ and HSY drafted the manuscript; WZQ, SXL, WYL, LXF, XYJ and HSY
contributed to revise the manuscript. All authors read and approved the final
manuscript.
Authors’ information
Zaiqiu Wang and Xiaoli Sun are co-first authors.
Acknowledgement
No acknowledgements should be stated.
Author details
1Department of General Surgery, Qilu Hospital of Shandong University, Jinan,
Shandong 250012, China. 2Department of Anorectal, Yuhuangding Hospital,
Yantai, Shandong 264000, China. 3Department of Laboratory, Yuhuangding
Hospital, Yantai, Shandong 264000, China. 4Department of Hepatobiliary,
Yuhuangding Hospital, Yantai, Shandong 264000, China.
Received: 25 March 2014 Accepted: 13 June 2014
Published: 30 July 2014
References
1. Fan NJ, Kang R, Ge XY, Li M, Liu Y, Chen HM, Gao CF: Identification
alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology
diagnosis biomarker of colorectal cancer. Diagn Pathol 2014, 9:53.
2. Chen C, Wang L, Liao Q, Huang Y, Ye H, Chen F, Xu L, Ye M, Duan S:
Hypermethylation of EDNRB promoter contributes to the risk of
colorectal cancer. Diagn Pathol 2013, 8:199.
3. Schmoll HJ, Stein A: Colorectal cancer in 2013: Towards improved drugs,
combinations and patient selection. Nat Rev Clin Oncol 2014, 11:79–80.
4. Yatabe J, Yatabe MS, Ishibashi K, Nozawa Y, Sanada H: Early detection of
colon cancer by amino acid profiling using AminoIndex Technology:
a case report. Diagn Pathol 2013, 8:203.5. Wang L, Cai S, Teng Z, Zhao X, Chen X, Bai X: Insulin therapy contributes
to the increased risk of colorectal cancer in diabetes patients: a meta-analysis.
Diagn Pathol 2013, 8:180.
6. Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z, Zhang H, Liu Y, Feng G, Li B, He L,
Ma J, Qin S, Yang Y: Identification of aberrant microRNA expression
pattern in pediatric gliomas by microarray. Diagn Pathol 2013, 8:158.
7. Wang S, Li H, Wang J, Wang D: Expression of microRNA-497 and its prognostic
significance in human breast cancer. Diagn Pathol 2013, 8:172.
8. Qin W, Zhang K, Clarke K, Weiland T, Sauter ER: Methylation and miRNA
Effects of Resveratrol on Mammary Tumors vs Normal Tissue. Nutr Cancer
2014, 66:270–277.
9. Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X,
Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J: Plasma
microRNA panel to diagnose hepatitis B virus-related hepatocellular
carcinoma. J Clin Oncol 2011, 29:4781–4788.
10. Tang W, Zhu J, Su S, Wu W, Liu Q, Su F, Yu F: MiR-27 as a prognostic
marker for breast cancer progression and patient survival. PLoS One 2012,
7:e51702.
11. Jahid S, Sun J, Edwards RA, Dizon D, Panarelli NC, Milsom JW, Sikandar SS,
Gümüs ZH, Lipkin SM: miR-23a promotes the transition from indolent to
invasive colorectal cancer. Cancer Discov 2012, 2:540–553.
12. Kupcinskas J, Wex T, Link A, Leja M, Bruzaite I, Steponaitiene R, Juzenas S,
Gyvyte U, Ivanauskas A, Ancans G, Petrenkiene V, Skieceviciene J, Kupcinskas L,
Malfertheiner P: Gene polymorphisms of micrornas in Helicobacter
pylori-induced high risk atrophic gastritis and gastric cancer. PLoS One
2014, 9:e87467.
13. Catucci I, Verderio P, Pizzamiglio S, Bernard L, Dall'olio V, Sardella D,
Ravagnani F, Galastri L, Barile M, Peissel B, Zaffaroni D, Manoukian S,
Radice P, Peterlongo P: The SNP rs895819 in miR-27a is not associated
with familial breast cancer risk in Italians. Breast Cancer Res Treat 2012,
133:805–807.
14. Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B,
Volkmann J, Varon R, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram
CR, Schmutzler RK, Burwinkel B: A genetic variant in the pre-miR-27a
oncogene is associated with a reduced familial breast cancer risk.
Breast Cancer Res Treat 2010, 121:693–702.
15. Sun Q, Gu H, Zeng Y, Xia Y, Wang Y, Jing Y, Yang L, Wang B: Hsa-mir-27a
genetic variant contributes to gastric cancer susceptibility through
affecting miR-27a and target gene expression. Cancer Sci 2010,
101:2241–2247.
16. Fu J, Tang W, Du P, Wang G, Chen W, Li J, Zhu Y, Gao J, Cui L: Identifying
microRNA-mRNA regulatory network in colorectal cancer by a
combination of expression profile and bioinformatics analysis. BMC Syst
Biol 2012, 6:68.
17. Kim TD, Lee SU, Yun S, Sun HN, Lee SH, Kim JW, Kim HM, Park SK, Lee CW,
Yoon SR, Greenberg PD, Choi I: Human microRNA-27a* targets Prf1 and
GzmB expression to regulate NK-cell cytotoxicity. Blood 2011,
118:5476–5486.
18. Del Follo-Martinez A, Banerjee N, Li X, Safe S, Mertens-Talcott S: Resveratrol
and quercetin in combination have anticancer activity in colon cancer
cells and repress oncogenic microRNA-27a. Nutr Cancer 2013, 65:494–504.
19. Zhou Y, Du WD, Chen G, Ruan J, Xu S, Zhou FS, Zuo XB, Lv ZJ, Zhang XJ:
Association analysis of genetic variants in microRNA networks and
gastric cancer risk in a Chinese Han population. J Cancer Res Clin Oncol
2012, 138:939–945.
20. Wang B, Ma N, Wang Y: Association between the hsa-mir-27a variant and
breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev 2012,
13:6207–6210.
21. Hezova R, Kovarikova A, Bienertova-Vasku J, Sachlova M, Redova M, Vasku A,
Svoboda M, Radova L, Kiss I, Vyzula R, Slaby O: Evaluation of SNPs in
miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.
World J Gastroenterol 2012, 18:2827–2831.
doi:10.1186/1746-1596-9-146
Cite this article as: Wang et al.: Association between miR-27a genetic
variants and susceptibility to colorectal cancer. Diagnostic Pathology
2014 9:146.
